Sender: |
|
Subject: |
|
From: |
|
Date: |
Wed, 7 Oct 1998 08:28:39 -0400 |
Content-Type: |
text/plain |
MIME-Version: |
1.0 |
Reply-To: |
|
Parts/Attachments: |
|
|
Xanax (Aprazolam)
Neonatal dose in milk is low at 3% of maternal dose which is unlikely to result
in pharmacological effect in infant. Case report of withdrawal symptoms
(irritability, crying, sleep disturbance) in infant
Anderson PO, McGuire GG. Neonatal aprazolam withdrawal-possible effects of
breastfeeding (letter), DICP The Annals of Pharmocotherapy 1989 Jul/Aug; 23:614.
Oo CY, Kuhn RJ, Desai N, Wright , McNamara PJ. Pharmacokinetics in lactating
women:predicition of aprazolam transfer into milk. Br J Clin Pharmacol 1995;
25:829-30.
Frank J. Nice. DPA, CPHP
Bethesda/Brookeville, MD
Formerly Plymouth, PA
|
|
|